-+ 0.00%
-+ 0.00%
-+ 0.00%

PLUS THERAPEUTICS GRANTED U.S. FDA ORPHAN DRUG DESIGNATION TO REYOBIQ™ IN PEDIATRIC MALIGNANT GLIOMAS

Reuters·04/08/2026 11:30:00

Please log in to view news